---
layout: post
title: "易瑞生物：2021年净利同比预增236%-297%"
date: 2022-01-19 19:44:36 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300942&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 300942_0" data-code="K 300942|0|2" data-code2="K 300942|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p>易瑞生物公告，预计2021年净利润2.2亿元-2.6亿元，同比增长236.16%-297.28%，公司新冠抗原检测试剂半成品及配套解决方案的订单、收入增长。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201192253791213>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)